By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying
Despite widespread support in polls for legalizing aid in dying, the number of people who go through with the practice remains very small.
Search
Filter
21 - 40 of 755 Results
-
The GOP Still Can’t Agree on a Health Plan
Episode 425Senate Democrats were promised a vote by mid-December on extending enhanced Affordable Care Act subsidies, but Republicans still can’t decide whether they want to put forward their own alternative or what that might include. Meanwhile, the CDC and FDA are roiled by debates over vaccines. Alice Miranda Ollstein of Politico, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews KFF Health News’ Aneri Pattani about her project tracking opioid settlement payments.
Crunch Time for ACA Tax Credits
Episode 426Dec. 15 is the deadline to sign up for Affordable Care Act plans that begin Jan. 1, and Congress remains at odds over letting expanded tax credits for the plans’ premiums expire and increasing the cost of insurance for millions of Americans. Meanwhile, HHS Secretary Robert F. Kennedy Jr. continues to remake vaccine policy to reflect ideology rather than science. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sheryl Gay Stolberg of The New York Times join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Georgetown professor Linda Blumberg about the GOP’s health plans.
-
Kennedy Swaps Vaccine Rhetoric for Story Time but Can’t Quite Change the Subject
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Amanda Seitz -
GOP Promotes MAHA Agenda in Bid To Avert Midterm Losses. Dems Point to Contradictions.
As fractures emerge in the Make America Great Again movement, some Republicans see its health-focused "MAHA" counterpart as the party’s next big thing. But doubts abound.
-
Journalists Follow the Fallout of CDC Director’s Firing and Trump’s Health Policies
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
A New CDC Nominee, Again
Episode 442Public Health Further Politicized Under the Threat of More Firings
Episode 415In a rambling news conference that shocked public health experts, President Donald Trump — without scientific evidence — blamed the over-the-counter drug acetaminophen, and too many childhood vaccines, for the increase in autism diagnoses in the U.S. That came days after a key immunization advisory panel, newly reconstituted with vaccine doubters, changed several long-standing recommendations. Former Centers for Disease Control and Prevention official Demetre Daskalakis joins KFF Health News’ Julie Rovner to discuss those stories. Meanwhile, Sandhya Raman of CQ Roll Call and Anna Edney of Bloomberg News join Rovner with the rest of the news, including a threat by the Trump administration to fire rather than furlough federal workers if Congress fails to fund the government beyond the Oct. 1 start of the new fiscal year.
-
RFK Jr. Made Promises in Order To Become Health Secretary. He’s Broken Many of Them.
Before being confirmed to lead the Department of Health and Human Services, Robert F. Kennedy Jr. told U.S. senators he would not cut funding for vaccine research or change the nation’s official vaccine recommendations. He did both.
By Amanda Seitz -
Immigrants With Health Conditions May Be Denied Visas Under New Trump Administration Guidance
The Trump administration has directed visa officers to consider common health ailments, including obesity and diabetes, when would-be immigrants seek visas to enter the U.S.
By Amanda Seitz Happy 60th, Medicare and Medicaid!
Episode 411This summer marks the 60th anniversary of Medicare and Medicaid, the twin government programs that have shaped the health care system into what it is today. In this special episode, KFF Health News’ Julie Rovner interviews two experts on the history, significance, and future of these programs: Medicare historian and University of North Carolina professor Jonathan Oberlander and George Washington University professor emerita Sara Rosenbaum, who has studied Medicaid since nearly its beginning and has helped shape Medicaid policy over the past four decades.
-
In Switching to Original Medicare, Beware of Medigap Plan Refusals
Open enrollment season lasts until March 31 for people enrolled in Medicare Advantage who want to switch to original Medicare, but there’s a potential hitch.
-
Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026
With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents — and they’re frustrated that the Trump administration isn’t doing more to limit its use.
By Julie Rovner -
Can Medicaid’s Popularity Shield It From the Budget Ax?
Republicans in Congress have suggested big cuts to Medicaid, the state-federal health insurance program for people with low incomes or disabilities. The complex, multifaceted program touches millions of Americans and has become deeply woven into state budgets and the U.S. health care system.
-
Harris Correct That Trump Fell Short on Promise To Negotiate Medicare Drug Prices
The former president instead favored a temporary model that could’ve brought down prices of some prescription drugs, but it was blocked by the courts.
-
Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
Adults ages 50 through 64 faced some of the steepest increases in out-of-pocket costs for Obamacare plans after a set of federal subsidies expired at the end of December. Some say they are putting off care or considering dropping health insurance coverage until Medicare picks up the bill.
-
Perspective
‘Alternative Facts’ Aren’t a Reason To Skip Vaccines
Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to defund mRNA research is just the latest to put ideology above public health.
-
Abortion Clinics — And Patients — Are on the Move, as State Laws Keep Shifting
Clinics in states where most abortions are legal, such as Kansas and Illinois, are reporting an influx of inquiries from patients hundreds of miles away — and are expanding in response. Despite the Supreme Court’s overturning of federal protections in 2022, abortions are now at their highest numbers in a decade.
-
Not Serious Enough To Turn on the Siren, Toddler’s 39-Mile Ambulance Ride Still Cost Over $9,000
After her son contracted a serious bacterial infection, an Ohio mother took the toddler to a nearby ER, and staffers there sent him to a children’s hospital in an ambulance. With no insurance, the family was hit with a $9,250 bill for the 40-minute ride.
By Tony Leys -
Off-Label Drug Helps One Boy With Autism Speak, Parents Say. But Experts Want More Data.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.